Macimorelin
Macimorelin (EP-1572), a GH secretagogue, is an orally active GHSR agonist. Macimorelin stimulates GH release. Macimorelin can be used in the research of adult growth hormone deficiency (AGHD), and Cancer anorexia-cachexia syndrome (CACS).
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 381231-18-1
- Formule: C26H30N6O3
- Masse moléculaire:474.55
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
GHSR[1]
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Intrahippocampal kainic acid (IHKA) mouse model[2]
-
Dosage:5 mg/kg
-
Administration:Intraperitoneal injection (i.p.), twice daily for 2 weeks.
-
Result:Significantly decreased the number and duration of seizures during the treatment period, but had no antiepileptogenic or disease-modifying effect.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 381231-18-1
-
Masse moléculaire 474.55
-
Formule C26H30N6O3
-
SMILES
O=CN[C@@H](CC1=CNC2=CC=CC=C12)NC([C@H](NC(C(C)(N)C)=O)CC3=CNC4=CC=CC=C34)=O
-
Synonyms
EP-1572; AEZS-130
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Jose M Garcia, et al. Macimorelin as a Diagnostic Test for Adult GH Deficiency. J Clin Endocrinol Metab. 2018 Aug 1;103(8):3083-3093. [Content Brief]
[2]. An Buckinx, et al. Translational potential of the ghrelin receptor agonist macimorelin for seizure suppression in pharmacoresistant epilepsy. Eur J Neurol. 2021 Sep;28(9):3100-3112. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)